Cargando…
Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238977/ https://www.ncbi.nlm.nih.gov/pubmed/30473754 http://dx.doi.org/10.18632/oncotarget.26304 |
_version_ | 1783371478911156224 |
---|---|
author | Novohradsky, Vojtech Zajac, Juraj Vrana, Oldrich Kasparkova, Jana Brabec, Viktor |
author_facet | Novohradsky, Vojtech Zajac, Juraj Vrana, Oldrich Kasparkova, Jana Brabec, Viktor |
author_sort | Novohradsky, Vojtech |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6238977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-62389772018-11-23 Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells Novohradsky, Vojtech Zajac, Juraj Vrana, Oldrich Kasparkova, Jana Brabec, Viktor Oncotarget Correction Impact Journals LLC 2018-10-30 /pmc/articles/PMC6238977/ /pubmed/30473754 http://dx.doi.org/10.18632/oncotarget.26304 Text en Copyright: © 2018 Novohradsky et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Novohradsky, Vojtech Zajac, Juraj Vrana, Oldrich Kasparkova, Jana Brabec, Viktor Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells |
title | Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells |
title_full | Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells |
title_fullStr | Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells |
title_full_unstemmed | Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells |
title_short | Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells |
title_sort | correction: simultaneous delivery of olaparib and carboplatin in pegylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238977/ https://www.ncbi.nlm.nih.gov/pubmed/30473754 http://dx.doi.org/10.18632/oncotarget.26304 |
work_keys_str_mv | AT novohradskyvojtech correctionsimultaneousdeliveryofolaparibandcarboplatininpegylatedliposomesimpartsthisdrugcombinationhypersensitivityandselectivityforbreasttumorcells AT zajacjuraj correctionsimultaneousdeliveryofolaparibandcarboplatininpegylatedliposomesimpartsthisdrugcombinationhypersensitivityandselectivityforbreasttumorcells AT vranaoldrich correctionsimultaneousdeliveryofolaparibandcarboplatininpegylatedliposomesimpartsthisdrugcombinationhypersensitivityandselectivityforbreasttumorcells AT kasparkovajana correctionsimultaneousdeliveryofolaparibandcarboplatininpegylatedliposomesimpartsthisdrugcombinationhypersensitivityandselectivityforbreasttumorcells AT brabecviktor correctionsimultaneousdeliveryofolaparibandcarboplatininpegylatedliposomesimpartsthisdrugcombinationhypersensitivityandselectivityforbreasttumorcells |